Genetic variants in telomere-maintenance genes and bladder cancer risk
- PMID: 22363464
- PMCID: PMC3281862
- DOI: 10.1371/journal.pone.0030665
Genetic variants in telomere-maintenance genes and bladder cancer risk
Abstract
Telomeres are critical in maintaining genomic stability. Genetic variants in telomere pathway genes may affect telomere and telomerase function, and subsequently cancer risk. We evaluated 126 SNPs from 10 genes related to telomere regulation in relation to bladder cancer risk. Five SNPs, 4 from TEP1 gene and 1 from PINX1 gene, were found to be highly significant (P<0.01). Out of these, the most significant association was found in rs2228041 of TEP1 (OR 1.66, 95% CI 1.19-2.31) while rs1469557 of PINX1 had a protective effect (OR 0.75, 95% CI 0.61-0.93). Haplotype analysis showed that a TEP1 haplotype consisting of the variant alleles of 7 SNPs exhibited a 2.28 fold increased risk (95% CI 1.13-4.60). We then performed cumulative analysis of multiple risk variants, as well as Classification and Regression Tree (CART) to look for gene-gene interactions. In cumulative effect analysis, the group with 4-5 risk variants had an OR of 2.57 (95% CI = 1.62-4.09) versus the reference group with 0 risk variants. The CART analysis categorized individuals into five subgroups with different bladder cancer risk profiles based on their distinct genotype background. To our knowledge, this is one of the largest, most comprehensive studies on bladder cancer risk concerning telomere-regulating pathway gene SNPs and our results support that genetic variations of telomere maintenance modulate bladder cancer risk individually and jointly.
Conflict of interest statement
Figures
Similar articles
-
Genetic variants in telomere-maintenance genes are associated with ovarian cancer risk and outcome.J Cell Mol Med. 2017 Mar;21(3):510-518. doi: 10.1111/jcmm.12995. Epub 2016 Nov 7. J Cell Mol Med. 2017. PMID: 28233473 Free PMC article.
-
Bladder cancer predisposition: a multigenic approach to DNA-repair and cell-cycle-control genes.Am J Hum Genet. 2006 Mar;78(3):464-79. doi: 10.1086/500848. Epub 2006 Jan 31. Am J Hum Genet. 2006. PMID: 16465622 Free PMC article.
-
Genetic variations in the transforming growth factor beta pathway as predictors of bladder cancer risk.PLoS One. 2012;7(12):e51758. doi: 10.1371/journal.pone.0051758. Epub 2012 Dec 12. PLoS One. 2012. PMID: 23251617 Free PMC article.
-
Genetic variants in telomerase reverse transcriptase (TERT) and telomerase-associated protein 1 (TEP1) and the risk of male infertility.Gene. 2014 Jan 25;534(2):139-43. doi: 10.1016/j.gene.2013.11.008. Epub 2013 Nov 20. Gene. 2014. PMID: 24269974
-
Walking the walk from genes through telomere maintenance to cancer risk.Cancer Prev Res (Phila). 2011 Apr;4(4):473-5. doi: 10.1158/1940-6207.CAPR-11-0066. Epub 2011 Apr 2. Cancer Prev Res (Phila). 2011. PMID: 21460394 Review.
Cited by
-
Genetic variants in telomere-maintenance genes are associated with ovarian cancer risk and outcome.J Cell Mol Med. 2017 Mar;21(3):510-518. doi: 10.1111/jcmm.12995. Epub 2016 Nov 7. J Cell Mol Med. 2017. PMID: 28233473 Free PMC article.
-
Opportunities and challenges for selected emerging technologies in cancer epidemiology: mitochondrial, epigenomic, metabolomic, and telomerase profiling.Cancer Epidemiol Biomarkers Prev. 2013 Feb;22(2):189-200. doi: 10.1158/1055-9965.EPI-12-1263. Epub 2012 Dec 14. Cancer Epidemiol Biomarkers Prev. 2013. PMID: 23242141 Free PMC article. Review.
-
Molecular Markers of Telomerase Complex for Patients with Pituitary Adenoma.Brain Sci. 2022 Jul 25;12(8):980. doi: 10.3390/brainsci12080980. Brain Sci. 2022. PMID: 35892421 Free PMC article.
-
Telomerase and drug resistance in cancer.Cell Mol Life Sci. 2017 Nov;74(22):4121-4132. doi: 10.1007/s00018-017-2573-2. Epub 2017 Jun 16. Cell Mol Life Sci. 2017. PMID: 28623509 Free PMC article. Review.
-
A screening-testing approach for detecting gene-environment interactions using sequential penalized and unpenalized multiple logistic regression.Pac Symp Biocomput. 2015:183-94. Pac Symp Biocomput. 2015. PMID: 25592580 Free PMC article.
References
-
- Blackburn EH, Greider CW, Szostak JW. Telomeres and telomerase: the path from maize, Tetrahymena and yeast to human cancer and aging. Nat Med. 2006;12:1133–1138. - PubMed
-
- Palm W, de Lange T. How Shelterin Protects Mammalian Telomeres. Annual Review of Genetics. 2008;42:301–334. - PubMed
-
- Blackburn EH. Telomeres and telomerase: their mechanisms of action and the effects of altering their functions. Febs Letters. 2005;579:859–862. - PubMed
-
- de Lange T. Shelterin: the protein complex that shapes and safeguards human telomeres. Genes Dev. 2005;19:2100–2110. - PubMed
-
- Blackburn EH. Switching and signaling at the telomere. Cell. 2001;106:661–673. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials